Skip to main content Skip to main content
Go to homepage

Gene therapy Zolgensma called 'medical miracle'

Kathryn Mosher, MD, director of the Neuromuscular Clinic at Akron Children's, discusses a new gene therapy that is saving the lives of young children with Spinal Muscular Atrophy (SMA), including 10 patients treated so far at Children's.

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.